Skip to main content

Table 1 Clinical characteristics of the cohort

From: Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores

Variables

N = 78

On admission

 Age, years (SD)

62 ± 11

 Male sex, n (%)

65 (83)

 Body mass index, kg/m2 (IQR)

27 (25-30)

 Ischemia time, minutes (IQR)

173 (140-239)

 Current smoker, n (%)

24 (31)

 Hypertension, n (%)

18 (23)

 Dyslipidemia, n (%)

6 (8)

 Previous angina, n (%)

9 (12)

 Previous known diabetes mellitus, n (%)

2 (3)

Treatment on admission

 Aspirin, n (%)

5 (6)

 Beta-blocker, n (%)

6 (8)

 ACE/ARB, n (%)

7 (9)

 Statin

6 (8)

Treatment at discharge

 Aspirin, n (%)

77 (99)

 Clopidogrel, n (%)

78 (100)

 Beta-blocker, n (%)

77 (99)

 ACE/ARB, n (%)

44 (56)

 Statin, n (%)

76 (97)

  1. Data are presented as number of patients and percentage in brackets for dichotomous variables or median and interquartile range. ACE angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, IQR inter-quartile range